Cover Image

IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation

Saved in:

Bibliographic Details
Main Authors:	Tristan V.M. Bruijn, MD (Author), Anne Geraedts, MD (Author), Carmen A. Vlahu, MD, PhD (Author), Lies.H. Jaspars, MD, PhD (Author), Yannick S. Elshot, MD (Author)
Format:	Book
Published:	Elsevier, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exacerbation of IgA nephropathy in a patient receiving dupilumab
by: Masako Yamamoto, MD, et al.
Published: (2022)

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
by: Dmitry Nedosekin, PhD, et al.
Published: (2021)

Successful treatment of refractory IgA vasculitis with tofacitinib
by: Yi-Fei Xu, MD, et al.
Published: (2022)

Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus
by: Adriana Maria Porro, et al.
Published: (2014)

IgG/IgA pemphigus with differing regional presentations
by: Hok Fai Cheng, MBBS (HK), et al.
Published: (2022)

Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
by: Ina Kreyberg, MD, PhD, et al.
Published: (2023)

Mixed IgM- and IgA-mediated epidermolysis bullosa acquisita associated with IgM-λ paraproteinemia in an 81-year-old woman
by: Thinh Chau, MD, et al.
Published: (2023)

Dermatitis herpetiformis with fibrillar IgA deposition and unusual histologic findings
by: Allen P. Miraflor, MD, et al.
Published: (2017)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms
by: Scott Stratman, MD, MPH, et al.
Published: (2024)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
by: Salama Hegazy, et al.
Published: (2016)

Linear IgA bullous dermatosis preceding a diagnosis of Crohn's disease
by: Nakisa B. Sadeghi, MPH, et al.
Published: (2023)

Pemphigus foliaceus masquerading as IgA pemphigus and responding to dapsone
by: Manas Chatterjee, et al.
Published: (2012)

Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
by: Laura Krogh Herlin, MD, et al.
Published: (2022)

Antineutrophil cytoplasmic antibody positivity and cutaneous IgA vasculitis in a patient with antisynthetase syndrome
by: Delfina Bur, BA, et al.
Published: (2021)

Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma
by: Michelle A. McNally, BSN, et al.
Published: (2021)

Endocarditis-associated IgA vasculitis: Two subtle presentations of endocarditis caused by Candida parapsilosis and Cardiobacterium hominis
by: Jake X. Wang, MD, et al.
Published: (2020)

Refractory pemphigus vulgaris successfully treated with ofatumumab
by: Daniel M. Klufas, MD, et al.
Published: (2020)

Skin manifestations of suspected COVID-19: Complications of the disease or reactivation of latent viral infections?
by: Mariko Sugawara-Mikami, MD, PhD, et al.
Published: (2021)

Navigating the initial diagnosis and management of adult IgA vasculitis: A reviewCapsule Summary
by: Brenna G. Kelly, BA, et al.
Published: (2022)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023)

The positive impact of rituximab on the quality of life and mental health in patients with pemphigus
by: Hanan Rashid, MD, et al.
Published: (2022)

Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
by: Fatima Bawany, MD, et al.
Published: (2023)

Revisiting the "jelly-roll" technique: New utility in diagnosing linear IgA bullous dermatosis mimicking toxic epidermal necrolysis
by: Samavia Khan, BS, et al.
Published: (2023)

IgG/IgA-pemphigus - extremely rare blistering autoimmune diseases
by: Arfenya E. Karamova, et al.
Published: (2020)

New onset pemphigus foliaceus during pregnancy: A rare case
by: M. Kokolios, MD, et al.
Published: (2018)

IgA vasculitis triggered by alcohol consumption in a 51-year-old man: A case report
by: Jenne P. Ingrassia, BA, et al.
Published: (2022)

Cocaine-induced pemphigus vulgaris
by: Margit L.W. Juhasz, MD, MSc, et al.
Published: (2021)

Mucosal linear IgA disease with esophageal involvement responsive to ustekinumab
by: Amber Jimenez, BS, et al.
Published: (2021)

Explosive bullous pemphigoid with high serum total IgE: Serum IgE as a biomarker that reflects disease activity
by: Hyun Jung Kwon, MD, et al.
Published: (2018)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
by: Dae San Yoo, MD, et al.
Published: (2020)

A case of IgA pemphigus with acantholysis in oral mucosal lesions
by: Ayumi Yamanishi, et al.
Published: (2024)

Localized pemphigus exacerbation associated with underlying breast cancer
by: Roberto Maglie, MD, et al.
Published: (2020)

Unusual external auditory canal relapse in pemphigus vulgaris
by: Noemi Coppola, DDS, et al.
Published: (2020)

Successful treatment with narrowband UVB in a recalcitrant case of IgA pemphigus
by: Lilian Lemos Costa, et al.
Published: (2023)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine
by: Joseph Han, BS, et al.
Published: (2022)

Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade
by: David M. Miller, MD, PhD, et al.
Published: (2017)

Severe recalcitrant cutaneous eruption with dual immune checkpoint blockade
by: Sakeena Fatima, BA, et al.
Published: (2018)

Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review
by: Toshihiko Matsuo MD, PhD, et al.
Published: (2022)

Refractory rheumatoid vasculitis complicated by cytomegalovirus reactivation as a manifestation of immune reconstitution inflammatory syndrome
by: Michie Katsuta, MD, PhD, et al.
Published: (2020)

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
by: Song Y. Park, MD, et al.
Published: (2021)